Modified release oral dosage form using co-polymer of polyvinyl acetate
AssigneeAstron Research Limited
InventorsShashank Bababhai PATEL, Kamala Sultansingh YADAV, Jayant Kumar MANDAL, Kirti Bansidhar MAHESHWARI
Life of this patent
Estimating the term…
Abstract
Once a day modified release oral dosage form comprising of granules or pellets which are either compressed into tablet or filled inside the capsule, wherein the pellet has a core of active ingredient coated on non pareil seeds with a rate controlling functional coating of co-polymer of polyvinyl acetate optionally with an intermediate separating coating between the core and the functional coating layer.
Claims20
Once a day modified release oral dosage form of active pharmaceutical ingredient with copolymer of polyvinyl acetate and pharmaceutically acceptable excipients.
Once a day modified release oral dosage form of venlafaxine or its pharmaceutically acceptable salt, comprising of non pareil seeds, venlafaxine hydrochloride, sodium alginate in the core coated with an intermediate barrier coating comprising of sodium alginate, glidant, opacifier and other pharmaceutically acceptable excipient and a final release controlling functional coating comprising of copolymer of polyvinyl acetate.
Once a day modified release oral dosage form of bupropion or its pharmaceutically acceptable salt, wherein the dosage form is a tablet comprising bupropion hydrochloride (25-50%), co-polymer of polyvinyl acetate (5-25%), and other pharmaceutically acceptable excipients.
(canceled)
Dependencies are inferred from the claim text.